LeadIQ logo
Learn more at LeadIQ.com
Oryzon Genomics SA

Oryzon Genomics SA Employee Directory

Biotechnology ResearchCatalonia, Spain51-200 Employees

Oryzon Genomics, S.A. is a clinical stage biopharmaceutical company and the European leader in the development of epigenetics-based therapeutics, with a strong focus on personalized medicine approaches to CNS disorders and oncology.
Oryzon has a broad and growing portfolio, with two compounds in clinical trials: iadademstat, a highly potent and selective LSD1 inhibitor, in Phase IIa clinical trials for the treatment of acute myeloid leukemia and small cell lung cancer, and vafidemstat, a CNS optimized LSD1 inhibitor in multiple Phase II trials for the treatment of CNS and psychiatric diseases. Phase IIb trials for both compounds are under preparation. Our pipeline also includes ORY-3001, a selective LSD1 inhibitor in preclinical development for the treatment of non-oncological diseases, and additional programs for developing inhibitors against other epigenetic targets. Oryzon has a strong technological platform for biomarker identification and performs biomarker and target validation for a variety of malignant and neurological diseases.
Oryzon has been listed on the Spanish Stock Exchange since December 2015 (ORY, ISIN Code: ES0167733015). Since then, the company has attracted specialized investors from US, Israel and Europe in several PIPEs led by different US investment banks.
The company was founded in 2000 and has offices in Spain and the United States.

Find Oryzon Genomics SA employees' phone numbers or email addresses

Oryzon Genomics SA Global Highlights

Location
Employees

Europe
75

Minus sign iconPlus sign icon
  • Spain
    72
  • Belgium
    1
  • Portugal
    1
  • France
    1

North America
5

Minus sign iconPlus sign icon
  • United States Of America
    5

South America
2

Minus sign iconPlus sign icon
  • Brazil
    1
  • Colombia
    1

Africa
1

Minus sign iconPlus sign icon
  • Morocco
    1

Oceania
1

Minus sign iconPlus sign icon
  • Australia
    1

Oryzon Genomics SA's Leadership

Contact profiles from Oryzon Genomics SA

Name
Title
Contact Info
Location
Last Update

Frequently Asked Questions

What is Oryzon Genomics SA known for?

Minus sign iconPlus sign icon
Oryzon Genomics SA was founded in 2000 operates in the Biotechnology Research industry. The company's main headquarters is located in Calle de Sant Ferran, 74 Cornellà de Llobregat, Catalonia 08940 ES. Explore Oryzon Genomics SA's company overview page for more information.

What is Oryzon Genomics SA's most common email format?

Minus sign iconPlus sign icon
Oryzon Genomics SA employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Oryzon Genomics SA email formats with LeadIQ.

How many employees does Oryzon Genomics SA have currently?

Minus sign iconPlus sign icon
Oryzon Genomics SA has approximately 57 employees as of September 2024. These team members are located across 5 continents, including EuropeNorth AmericaSouth America.

Who are Oryzon Genomics SA's key employees and leadership?

Minus sign iconPlus sign icon

As of September 2024, Oryzon Genomics SA's key employees include:

  • Chief Medical Officer, Cns Clinical Development: M. T. R.
  • Chief Medical Officer: D. V. F.
  • Chief Scientific Officer: J. X. P.
  • Chief Intellectual Property Officer: N. V.
  • Chief Of Clinical Operations: S. G.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.